Hvivo PLC (LON:HVO) insider James Winschel bought 2,221 shares of the firm’s stock in a transaction on Tuesday, October 11th. The stock was acquired at an average cost of GBX 180 ($2.23) per share, for a total transaction of £3,997.80 ($4,947.77).
Shares of Hvivo PLC (LON:HVO) opened at 173.00 on Thursday. The stock’s 50 day moving average is GBX 178.79 and its 200-day moving average is GBX 186.27. The firm’s market cap is GBX 135.05 million. Hvivo PLC has a one year low of GBX 167.00 and a one year high of GBX 280.00.
Separately, Numis Securities Ltd restated an “add” rating and set a GBX 210 ($2.60) price target on shares of Hvivo PLC in a report on Thursday, September 22nd.
Hvivo PLC Company Profile
hVIVO plc, formerly Retroscreen Virology Group plc, is a holding company. The Company is engaged in a life sciences business pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, respiratory syncytial virus (RSV), asthma and common cold.
Receive News & Ratings for Hvivo PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hvivo PLC and related companies with MarketBeat.com's FREE daily email newsletter.